BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19400993)

  • 1. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
    Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
    Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B; Yumusak OH; Tokmak A
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.
    López E; Gunby J; Daya S; Parrilla JJ; Abad L; Balasch J
    Reprod Biomed Online; 2004 Oct; 9(4):382-90. PubMed ID: 15511336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).
    Buckler HM; Robertson WR; Anderson A; Vickers M; Lambert A
    Hum Reprod; 1999 Dec; 14(12):2969-73. PubMed ID: 10601080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
    Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A
    Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.
    Dale O; Tanbo T; Lunde O; Abyholm T
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
    Balasch J; Fábregues F; Creus M; Casamitjana R; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Nov; 17(10):561-5. PubMed ID: 11209536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W; Zhang Y; Dai Q
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study.
    Homburg R; Hendriks ML; König TE; Anderson RA; Balen AH; Brincat M; Child T; Davies M; D'Hooghe T; Martinez A; Rajkhowa M; Rueda-Saenz R; Hompes P; Lambalk CB
    Hum Reprod; 2012 Feb; 27(2):468-73. PubMed ID: 22128296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H; Sezik M; Ozkaya O
    J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome.
    van Dessel HJ; Donderwinkel PF; Coelingh Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jan; 9(1):55-6. PubMed ID: 8195351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van Der Veen F
    Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone.
    Yildizhan R; Adali E; Kolusari A; Kurdoglu M; Yildizhan B; Sahin HG; Kamaci M
    J Int Med Res; 2008; 36(6):1197-204. PubMed ID: 19094427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.
    van Wely M; Bayram N; van der Veen F; Bossuyt PM
    Hum Reprod; 2005 Jul; 20(7):1827-32. PubMed ID: 15831514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.